Table 1.
Analysis of 31P-MRS-detected metabolic changes following inhibition with MK-2206 in
PC3 | ||||||||
---|---|---|---|---|---|---|---|---|
6 h (5xGI50) | P | 12 h (5xGI50) | P | 24 h (5xGI50) | P | 24 h (3xGI50) | P | |
PE | 62 ± 16 | 0.008 | 47 ± 11 | 0.001 | 23 ± 16 | 0.0001 | 43 ± 26 | 0.01 |
PC | 74 ± 14 | 0.02 | 78 ± 11 | 0.02 | 69 ± 13 | 0.001 | 71 ± 5 | 0.0004 |
GPE | 66 ± 34 | ns | 50 ± 12 | 0.001 | 320 ± 104 | 0.005 | 153 ± 40 | ns |
GPC | 32 ± 16 | 0.001 | 36 ± 11 | 0.0003 | 225 ± 63 | 0.007 | 121 ± 27 | ns |
PCr | 74 ± 28 | ns | 54 ± 31 | 0.04 | 38 ± 24 | 0.007 | 46 ± 24 | 0.01 |
NTP | 63 ± 17 | 0.01 | 56 ± 12 | 0.002 | 68 ± 18 | 0.005 | 82 ± 11 | 0.03 |
HT29 | ||
---|---|---|
24 h (5xGI50) | P | |
PE | 60 ± 9 | 0.001 |
PC | 67 ± 6 | 0.0001 |
GPE | 132 ± 26 | 0.04 |
GPC | 169 ± 31 | 0.004 |
PCr | 59 ± 8 | 0.0001 |
NTP | 89 ± 7 | 0.02 |
Data are expressed as %T/C and presented as the mean ± SD, n ≥ 4
Two-tailed unpaired t test was used to compare results in treated cells to controls within the same time-point